- Investing Ideas
- /
- US Artificial Intelligence (AI) Powered Medical Diagnosis Stocks
US Artificial Intelligence (AI) Powered Medical Diagnosis Stocks
Results
21
21 companies
Medtronic
Market Cap: US$113.5b
Develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide.
MDT
US$88.86
7D
0.7%
1Y
4.5%
Tempus AI
Market Cap: US$8.2b
Operates as a healthcare technology company.
TEM
US$49.89
7D
-6.3%
1Y
n/a
Lantheus Holdings
Market Cap: US$6.7b
Develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide.
LNTH
US$97.42
7D
-1.0%
1Y
64.6%
Guardant Health
Market Cap: US$5.2b
A precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally.
GH
US$43.49
7D
-5.1%
1Y
120.8%
RadNet
Market Cap: US$3.7b
Provides outpatient diagnostic imaging services in the United States and internationally.
RDNT
US$52.51
7D
3.5%
1Y
9.3%
Veradigm
Market Cap: US$720.7m
A healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally.
MDRX
US$4.25
7D
-0.1%
1Y
-45.9%
CeriBell
Market Cap: US$673.2m
Operates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States.
CBLL
US$19.24
7D
-1.7%
1Y
n/a
Guerbet
Market Cap: €327.8m
Engages in the development and marketing of contrast media products, delivery systems, medical devices, and related solutions.
GBTP
€30.03
7D
0%
1Y
n/a
Nano-X Imaging
Market Cap: US$308.0m
Develops a commercial-grade tomographic imaging device with a digital X-ray source.
NNOX
US$4.91
7D
-12.5%
1Y
-54.8%
Light AI
Market Cap: US$70.9m
A healthcare company, focuses on developing artificial intelligence health diagnostic solutions.
OHCF.F
US$0.42
7D
5.0%
1Y
n/a
Renalytix
Market Cap: US$29.8m
Develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management kidney diseases in the United States.
RNLX.Y
US$0.20
7D
-1.3%
1Y
-75.3%
Renalytix
Market Cap: US$29.8m
Develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management kidney diseases in the United States.
RENX.F
US$0.091
7D
0%
1Y
n/a
Spectral AI
Market Cap: US$27.1m
An artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States.
MDAI
US$1.29
7D
-3.7%
1Y
-47.8%
Acarix
Market Cap: US$246.8m
A medical device company, develops solutions for rapid AI-based coronary artery disease (CAD) rule-out.
ACIX.F
US$0.027
7D
24.5%
1Y
n/a
OneMedNet
Market Cap: US$15.3m
Provides clinical imaging solutions.
ONMD
US$0.54
7D
-7.5%
1Y
-49.0%
America Great Health
Market Cap: US$10.6m
Operates as a biotechnology company in the United States.
AAGH
US$0.0005
7D
-16.7%
1Y
-81.2%
TrivarX
Market Cap: US$7.9m
A health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States.
MDBI.F
US$0.0021
7D
0%
1Y
n/a
IQ-AI
Market Cap: US$2.7m
Through its subsidiaries, provides clinical treatments to patients in the field of medical imaging diagnostics primarily in the United States.
IQAI.F
US$0.02
7D
0%
1Y
n/a
HeartSciences
Market Cap: US$3.0m
A medical technology company, focuses on applying AI-based technology to an ECG to enhance its clinical utility.
HSCS
US$2.80
7D
-3.9%
1Y
-73.5%
Aspira Women's Health
Market Cap: US$2.9m
Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States.
AWH
US$0.11
7D
1.9%
1Y
-96.2%
EvokAI Creative Labs
Market Cap: US$874.6k
A MedTech artificial-intelligence (AI)-powered company, engages in the development of transformational technologies for the healthcare sector.
OKAI.F
US$0.17
7D
0%
1Y
n/a